Kim, Ki-Yoon
Hwang, Jawon
Park, Sung Hyun
Cho, Minah
Kim, Yoo Min
Kim, Hyoung-Il
Hyung, Woo Jin http://orcid.org/0000-0002-8593-9214
Funding for this research was provided by:
Investigator Sponsored Research Program (ISR-2017-10924)
Medtronic (Covidien Private Limited)
Article History
Received: 17 October 2023
Accepted: 14 February 2024
First Online: 19 March 2024
Declarations
:
: This study was supported by a grant from the Investigator Sponsored Research Program (ISR-2017–10924) and Covidien Private Limited (Medtronic). The funding sources played no role in the design of this study and did not play any role in study execution, data analysis, data interpretation, or the decision to submit the results for presentation or publication. W.J.H. had full access to all data in the study and took responsibility for the integrity of the data and the accuracy of data analysis. W.J.H. is a stockholder and chief executive officer of Hutom. He received research grants from Medtronic and GC Pharma. He provided consultancy services to SK Hynix (Wuxi) outside of the submitted work. The other authors declare no conflicts of interest.